News and Events

MAMMOSCREEN is a proud partner of the Cluster on Cancer “Prevention and Early Detection”, which has launched its LinkedIn channel. The new logo of the...

Dear Reader, A warm welcome to our Newsletter. In December 2022, the MammoScreen Project was awarded 7 million euros by the European Health and Digital...

Siobhán Freeney is the coordinator of the MammoScreen Project Patient Advisory Group (PAG).  She was diagnosed with stage 3 Invasive Lobular Carcinoma (ILC) in December...

Meet the MAMMOSCREEN Coordination and Management Team at Fondazione Toscana Life Sciences (TLS). Fondazione Toscana Life Sciences is a non-profit research organization based in Siena,...

The MammoScreen clinical study involves 9 centres in five different European countries – Italy, Poland, Portugal, Spain and Switzerland – and will recruit 10.000 women...

MammoWave works differently from traditional methods that use X-rays. The device generates a qualitative representation of the breast tissues by processing very low power (<1...

Last 22 and 23 November 2023, all the partners, the members of the Scientific and Ethics Advisory Boards and Patient Advisory Group involved in the...

The first Annual Meeting of the “Prevention and early detection (Screening)” Cluster of projects will be held on September 7th in San Sebastian, Spain.  In...

Calling all women: Be heard and make a difference!  Are you a healthy woman, someone with a predisposition for hereditary cancer, or a brave fighter...

The first MammoScreen Webinar with Patient Advocates and Patient Advocay Groups is scheduled on 4th September 2023, 13.30-15 PM CEST, via ZOOM. The primary purpose...

It is with great pleasure that we announce that MAMMOSCREEN has joined the EU funded projects cluster on cancer “Prevention and early detection (Screening)”. Under...